Literature DB >> 3264131

New sensitive bioassay for sulbactam in bovine tissues.

G H Keeler1, J P Stankewich, A E Girard, J J Rash.   

Abstract

A quantitative cylinder plate bioassay for sulbactam has been developed which can detect concentrations as low as 0.01 microgram/g in bovine muscle, fat, kidney, and liver tissues. This procedure may also be applicable to human tissues and fluids. In addition to the improved sensitivity, this method differs from all previously described systems because it is based on inhibition by sulbactam of a cell-free beta-lactamase incorporated in the assay agar. The assay is unaffected by the presence of ampicillin even at concentrations 10 times that of the sulbactam concentration. This report describes the analytical technique as well as the accuracy and precision of the method. The assay can be applied to tissue depletion studies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264131      PMCID: PMC175865          DOI: 10.1128/AAC.32.9.1347

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Assays of sulbactam in the presence of ampicillin.

Authors:  G Foulds; D J Gans; D Girard; T J Whall
Journal:  Ther Drug Monit       Date:  1986       Impact factor: 3.681

2.  Automated plate diffusion zone measurement and computerized data handling.

Authors:  R B Dardas; J H Perry; Z A Coles; C G Iwanicki
Journal:  Bull Parenter Drug Assoc       Date:  1973 Jul-Aug

3.  CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization.

Authors:  A R English; J A Retsema; A E Girard; J E Lynch; W E Barth
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

4.  Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration.

Authors:  R M Brown; R Wise; J M Andrews; J Hancox
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

5.  The elimination of sulbactam alone and combined with ampicillin in patients with renal dysfunction.

Authors:  N Wright; R Wise
Journal:  J Antimicrob Chemother       Date:  1983-06       Impact factor: 5.790

6.  Pharmacokinetics of sultamicillin in mice, rats, and dogs.

Authors:  A R English; D Girard; S L Haskell
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

7.  Pharmacokinetics of potassium clavulanate in combination with amoxicillin in pediatric patients.

Authors:  J D Nelson; H Kusmiesz; S Shelton
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

8.  CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides.

Authors:  J A Retsema; A R English; A E Girard
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.